Clinical Trials Logo

Clinical Trial Summary

A retrospective analysis of medical records at Far Eastern Memorial Hospital from January 2008 to May 2020 about female patients with overactive bladder syndrome, who received Solifenacin or Mirabegron as the initial treatment. Factors affecting persistence of OAB medications will be analyzed.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05040984
Study type Observational
Source Far Eastern Memorial Hospital
Contact Sheng-Mou Hsiao, MD
Phone +886919302632
Email [email protected]
Status Recruiting
Start date April 30, 2021
Completion date January 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT02540707 - Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes Phase 4
Completed NCT01114412 - Basic Sensations Coming From the Bladder
Recruiting NCT03952299 - Oxybutynin for Post-surgical Bladder Pain and Urgency Phase 3
Active, not recruiting NCT03758235 - Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin Phase 3
Completed NCT01912885 - Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome N/A
Recruiting NCT04873037 - BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder N/A
Completed NCT04300400 - Treatment of the Overactive Bladder Syndrome: A Delphi Study
Recruiting NCT04982120 - Use of Repris Needle in Bladder Injection N/A
Recruiting NCT04256876 - TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I) N/A
Not yet recruiting NCT03331081 - Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome N/A
Completed NCT02024945 - Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome Phase 4
Completed NCT00546637 - Fesoterodine "add-on" Male Overactive Bladder Study Phase 3
Recruiting NCT03044912 - Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan Phase 3
Recruiting NCT03817203 - Effects of Kinesio Taping Application in Women With Overactive Bladder N/A
Recruiting NCT03755089 - Oral vs Intravesical Analgesia for Office Bladder Botox Injections Phase 4
Recruiting NCT01876186 - Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients Phase 4
Completed NCT03532789 - Herbal Patch for Overactive Bladder Phase 2/Phase 3
Completed NCT03250650 - Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment N/A
Recruiting NCT04909255 - Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder Phase 4
Completed NCT01819168 - Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing N/A